Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 15.2.2024KRKA, d.d., Novo mesto (KRK-2)2714DNebivolol Krka 5 mg tablety (tbl 90x5 mg (blis.PVC/PVDC/Al))19.2.2024R
 15.2.2024KRKA, d.d., Novo mesto (KRK-2)3487BArisppa 15 mg tablety (tbl 60x15 mg (blis.OPA/Al/PVC/Al))19.2.2024O
 15.2.2024KRKA, d.d., Novo mesto (KRK-2)3492BArisppa 10 mg tablety (tbl 14x10 mg (blis.OPA/Al/PVC/Al))19.2.2024R
 15.2.2024KRKA, d.d., Novo mesto (KRK-2)40538Atoris 20 (tbl flm 30x20 mg (blis.OPA/Al/PVC/Al))19.2.2024O
 15.2.2024KRKA, d.d., Novo mesto (KRK-2)4594AEmanera 20 mg tvrdé gastrorezistentné kapsuly (cps end 90x20 mg (blis.OPA/Al/PVC/Al))19.2.2024O
 15.2.2024KRKA, d.d., Novo mesto (KRK-2)7945ACo-Amlessa 8 mg/5 mg/2,5 mg tablety (tbl 90x8 mg/5 mg/2,5 mg (blis.OPA/Al/PVC/Al))19.2.2024O
 15.2.2024Sandoz Pharmaceuticals d.d. (SAN-SLO-1)00530Amoksiklav 1000 mg granulát na perorálnu suspenziu (gru por 12x(875 mg+125 mg) (vre.papier/PE/Al/PE))12.2.2024O
 15.2.2024Sandoz Pharmaceuticals d.d. (SAN-SLO-1)12735Doxyhexal 200 Tabs (tbl 10x200 mg (blis.PP/Al))12.2.2024R
 15.2.2024Sandoz Pharmaceuticals d.d. (SAN-SLO-1)3008DDailiport 5 mg (cps pld 30x1x5 mg (blis.PVC/PVDC/Al-jednotliv.dáv.))12.2.2024O
 15.2.2024Sandoz Pharmaceuticals d.d. (SAN-SLO-1)39782Azithromycin Sandoz 200 mg/5 ml prášok na perorálnu suspenziu (plu por 1x800 mg (800 mg/20 ml) (fľ. HDPE) (PE/PP inj. striek.))12.2.2024O
 15.2.2024Sandoz Pharmaceuticals d.d. (SAN-SLO-1)45710Lekoklar XL 500 mg tablety s riadeným uvoľňovaním (tbl mod 7x500 mg (blis.Al/Al))12.2.2024R
 15.2.2024Sandoz Pharmaceuticals d.d. (SAN-SLO-1)5367BAripiprazol Sandoz 10 mg orodispergovateľné tablety (tbl oro 56x10 mg (blis.papier/PET/Al/PVC/Al/OPA))12.2.2024O
 15.2.2024Sandoz Pharmaceuticals d.d. (SAN-SLO-1)5381BAripiprazol Sandoz 15 mg orodispergovateľné tablety (tbl oro 56x15 mg (blis.papier/PET/Al/PVC/Al/OPA))12.2.2024O
 15.2.2024Sandoz Pharmaceuticals d.d. (SAN-SLO-1)7951DAbiraterón Sandoz 1000 mg filmom obalené tablety (tbl flm 30x1000 mg (blis.Al/OPA/Al/PVC))12.2.2024O
 15.2.2024Sandoz Pharmaceuticals d.d. (SAN-SLO-1)1695CIvabradín Sandoz 7,5 mg (tbl flm 56x7,5 mg (blis.PVC/PE/PVDC/Al))12.2.2024R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)